Dabur India receives SEBI administrative warning letter

Dabur India Ltd has received an administrative warning letter from the Securities and Exchange Board of India (SEBI) alleging a violation of SEBI Listing Regulations. The violation pertains to the delay in disclosing a warning letter received from the US FDA on July 24, 2026. SEBI has advised the company to be careful in the future to avoid recurrence of such lapses. Dabur India stated that there is no impact on its financial or operational activities and that it has always been compliant with SEBI regulations. The company will take necessary steps to address the concerns mentioned in the letter.